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By
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ABSTRACT
Private health players in emerging countries have increased their presence and contributed to
global health issues, but have been undervalued in financing. A variety of health players have evolved and
hospitals have played a pivotal role. However, hospitals in developing countries face significant
challenges in getting the financing they need to expand their operations by adding additional facilities and
equipment partly due to under valuation. The objective of the thesis is to understand the fundamental
values of those hospitals in emerging countries and to learn why under valuation happens by conducting
the case valuation of Life Healthcare.
This thesis is primarily intended to serve as an investment guide for potential investors and
financers, such as commercial banks, investment funds, microfinance institutions, leasing companies, and
other types of financial institutions. It discusses how the enterprise value should be assessed. The
secondary audience is hospital management teams who want to understand the source of hospital value
and key potential drivers for improvement. The thesis conducts the sensitivity analysis to identify how the
key drivers affect the enterprise value. Accordingly, management teams can identify where to improve to
maximize corporate values and satisfy customer needs. For these purposes, the thesis will be structured as
follows. Summarizing recent trends of private healthcare industries in emerging countries, it starts with
explanation of hospital business models and survey results of the financial issues in Romania. After
examining two different valuation approaches, the paper will conduct valuation with the discounted cash
flow model, taking the example of Life Healthcare Group, a private healthcare player in South Africa.
The valuation results with third-party estimations identify the different assumptions, especially in terms
of market growth and the weighted average cost of capital. Finally, the paper will explore other valuation
issues and improvement ideas based on valuation results and comparative analysis.
Thesis Supervisor: Anjali Sastry
Title: Senior Lecturer
2
Table of contents
1. Introduction................................................................................................................................ 4
1-1. Healthcare issues in emerging countries......................................................................... 4
1-2. Thesis objective and structure........................................................................................ 7
2. Hospital business and financial challenges............................................................................. 8
2-1. Hospital business models................................................................................................. 8
2-2. Financial needs and challenges in em erging countries ................................................... 9
3. Case: Life Healthcare in South Africa .................................................................................. 12
3-1. Healthcare environment in South Africa ....................................................................... 12
3-2. Business m odel of Life Healthcare ............................................................................... 14
3-3. Key business drivers ......................................................................................................... 17
3-4. Risks and considerations............................................................................................... 19
4. Valuation.................................................................................................................................. 19
4-1. M ultiples ........................................................................................................................... 20
4-2. Discounted cash flow ........................................................................................................ 21
4-3. Valuation of Life Healthcare ........................................................................................ 23
4-4. Key assum ption................................................................................................................. 23
4-5. Valuation results ............................................................................................................... 25
5. Lessons and next steps............................................................................................................. 27
5-1. Lessons.............................................................................................................................. 27
5-2. N ext steps.......................................................................................................................... 29
Acknow ledgem ents: ...................................................................................................................... 29
Bibliography:. ................................................................................................................................ 30
3
1. Introduction
The chapter briefly covers the context, the private healthcare sector trend in emerging
countries. Smith (2003) reports the fundamental roles of private healthcare players and IFC
(2011) categorizes the industry. After reviewing major types of private healthcare business, the
paper explains the structure in following chapters.
1-1. Healthcare issues in einerging countries
The private healthcare sector is growing rapidly in emerging market countries. Across the
developing world, people are increasingly relying on private healthcare organizations to address
their health needs. This trend will continue due to the fundamentals that drive demand, namely,
population growth, increasing life expectancy, growing disease burdens, and patient demand for
treatment. As a result, the private healthcare sector in emerging markets can offer attractive
returns to investors from both commercial and social perspectives. The sector is not without its
challenges. Consequently, financial institutions, which are often unfamiliar with its
characteristics and dynamics, perceive it as risky. As a result, many private healthcare
organizations in developing countries, particularly small- and medium-sized enterprises (SMEs),
remain underfinanced and hindered from achieving their full potential.
The private healthcare sector is diverse, with financing needs ranging from small-scale to
large capital investments. Investors need to be able to segment the market. A country's
healthcare system consists of both public and private sectors, with the private sector increasingly
complementing public services. While the size and responsibilities of the private sector varies by
country, it is usually diverse, representing a broad range of for-profit businesses and not-for-
profit organizations. The private healthcare sector includes various categories businesses. IFC
(2011) categorized the sector. The first category is health service providers: primary care,
hospitals, clinics, hospices, elderly and residential care, psychiatric care, occupational health,
alternative medicine, traditional medicine, ambulances, diagnostic services, and telemedicine
models. The second category is retailers and distributors: pharmacies, drug shops, and
pharmaceutical distributors. The third category is medical education and training institutes:
medical schools, nursing and paramedical schools, and eLearning platforms. The fourth category
includes financing entities such as health management organizations (HMOs), medical plans,
insurance companies, and other risk-pooling entities. Manufacturing is the last category; it
includes manufacturers of pharmaceuticals, medical supplies, medical equipment, and
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biosciences. The table below shows the current major players in the private healthcare industry.
As shown, private players are pivotal in the healthcare sector.
Exhibit 1
Commercial Healthcare business in emerging countries
General Hospital Groups Netcare, Life Healthcare, and Mediclinic South Africa
Apollo Hospitals, Max India, and Fortis India
Acibadem and Medical Park Turkey
Saudi German Hospitals Saudi Arabia, Egypt
Rede D'Or Brazil
Columbia Asia Malaysia, India
United Family Hospitals and Clinics China
MedLife Romania
Hygeia Nigeria Nigeria
Specialist Hospitals Wuhan Asia Heart Hospital China
Andalusia Women and Child Hospitals Egypt
Nairobi Women's Hospital Kenya
Polyclinics Intergramedica Chile
Medicover Poland, Romania
MediClub Azerbaijan, Georgia
Specialist clinics Aier Eye Hospital China
Dunya Eye Hospitals Turkey
Magrabi Centers Middle East
Jiamei China
Euromedic Internationals Eastern Europe
Asia Renal Care East Asia
Primary care clinics Healthway Medical Singapore
Al Borg Laboratory Egypt
Fieury Brazil
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Telemedicine Teleradiology Solutions India
Distributors/Retailers Aversi Georgia
Mercury Drug Corporation Philippines
Famacas Cruz Verde Chile
Medical schools University of Science and Tech Yemen
Batterjee Medical College Saudi Arabia
Nursing schools De La Salle Health Sciences Institute Philippines
Mayanja Memorial Training Institute Uganda
Source: IFC, Bloomberg, author's analysis
While providing a brief overview of the healthcare sector, the scope of this thesis is on
health service providers, which represent the largest area of healthcare spending. This paper will
focus on hospital business evaluation in emerging counties. Hospitals are delivery channels for
medical products and services. In emerging countries, the most common types of health service
providers are individuals and SMEs. Hospitals offer significant job creation in a variety of
professions. Medical professionals include physicians, dentists, nurses, midwives, pharmacists,
and other clinical professionals, often collectively referred to as "clinicians." These may be
individuals who are employed or those working as sole practitioners.
In the hospital business, IFC (2011) mentions three different types of retailers. The first is
the clinic, which includes standalone primary care or outpatient facilities employing a small
number of staff. Typically, medical professionals, either a sole practitioner or a small group or
partnership, own these businesses, although they may be owned or managed by nonclinicians.
The second is the general hospital. These are more sophisticated healthcare facilities that are
capable of performing more advanced tests and procedures and admitting patients overnight.
Most private hospitals in developing countries have fewer than 50 beds. Hospitals generally
provide inpatient and outpatient care and surgery and may have diagnostic capabilities and a
pharmacy on the premises. They may be physician owned but it is increasingly common to have
non-physician owners of private hospitals, such as property developers, other types of
entrepreneurs, and publicly traded company ownership. Finally, diagnostic facilities are often
integrated within a hospital structure. It is also common for the private health sector to include
standalone laboratories or other diagnostic facility business models.
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Exhibit 2
Private Hospitals (Listed on the stock market) Case Org
Name HQ Location
Life healthcare group South Africa
Mediclinic international South Africa
Netcare South Africa
Apollo Hospitals India
Fortis Healthcare India
IHH Malaysia
KPJ Healthcare Malaysia
Bangkok dusit medical services Thailand
Bumrungrad hospital Thailand
Ramsay Healthcare Australia
Source: Bloomberg, Analyst reports, Company website
The table above is a list of commercial hospitals in emerging countries. They are listed on
the stock market in local countries. In the hospital sector, commercial hospital organizations
increased their presence by capturing the specific needs of medical tourism. Compared with
hospitals in developed countries, the number of listed organizations is limited and their focuses
are international medical tourism and high-end patients who can afford to pay. In emerging
countries, hospitals offer high-quality operations at low cost and attract patients from advanced
economies. As the economy has grown in emerging countries, private hospitals could then
capture high-end customers since those segments are not satisfied with public services and they
shift to the private sector to seek better quality healthcare services.
1-2. Thesis objective and structure
This thesis is primarily intended to serve as an investment guide for potential investors
and financers, such as commercial banks, investment funds, microfinance institutions (MFIs),
leasing companies, and other types of financial institutions. Reflecting the typical profile of the
sector, the guide focuses mainly on hospitals in emerging countries. It aims to reveal potential
market opportunities, to promote an understanding of the most common business models, and to
assist investors in how to identify opportunities and evaluate potential targets. It also discusses
the most common risks and barriers that face investors in the sector as well as ways to manage
these risks and overcome barriers.
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The secondary audience would be hospital management teams who want to understand
the sources of hospital value and key potential drivers for improvement. This thesis also aims to
offer the investors' view, namely, how they evaluate hospital organization value as equity
investment assets. Accordingly, the management team can identify where to improve to
maximize corporate values and satisfy customer needs.
The thesis will be structured as follows. First, to understand why the fair valuation in the
emerging country is required, the thesis discusses the financial needs and challenges of hospitals
in emerging countries, taking the example of Romania. There are a variety of financial needs but
most of them are not yet fulfilled. Second, we will cover frameworks to understand the hospital
business model to reflect on the case valuation of Life Healthcare. They are relevant to the
valuation approach in later chapters. Next, the thesis will shift to a case study of Life Healthcare.
This organization is one of the major hospital chains in South Africa that focuses on private
health areas in the domestic market. Other big hospital chains in emerging countries target
medical tourists from advanced economies with cheap operation fees. This chapter starts by
examining the healthcare environment in South Africa and then explores its business model,
financial analysis, key business drivers, and potential risks in the future. Based on historical
analysis and future trend, the next chapter examines corporate values based on the discounted
cash flow approach after discussing two commonly used methodologies. The thesis makes
assumptions regarding business drivers and key financial ratios. After the evaluation, the paper
covers sensitivity analysis and benchmark analysis with other valuations from investment banks.
The final chapter explores key considerations in evaluating the hospital business and remaining
issues.
2. Hospital business and financial challenges
The chapter reviews a basic hospital revenue formula and assesses typical the financial
needs and challenges in Romania from the hospital survey by USAID (2007). It also provides the
objective why the fair valuation is important in emerging countries.
2-1. Hospital business models
Generally, the hospital business is divided into two revenue categories, the number of
patients and the revenue per patient. The number of patients is driven by market size, brand
image of hospitals, and the supply of services. The key actions are to add new beds and facilities
to accept a large number of customers. The second revenue category is revenue by patient.
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Increasing revenue by patient involves offering value-added services that customers can afford to
pay. To attract affluent customers, hospitals need to arrange the necessary equipment and
medical professionals. Then, hospitals can provide high-quality services, including challenging
operations. Therefore, hospitals in emerging countries, where middle- and high-income
customers are expected to increase in the future, must identify their financial needs.
Exhibit 3
Revenue formula of hospital
Key Levers
New beds/
facilities
* Quality of
services
Equipment
2-2. Financial needs and challenges in emerging countries
USAID (2007, 2008, and 2009) conducted intensive research projects to understand
hospital business and its financial needs in Romania, Zambia, and Nigeria. Due to similarity with
South Africa which the paper will cover in the next chapter, the thesis examines Romania to
examine financial needs in emerging countries. Research surveys on Zambia and Nigeria also
report quite similar financial needs and challenges. According to the IMF and World Bank, the
GDP per capita in Romania is USD 7,667 while that in South Africa is USD 6,090. Both
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Romania and South Africa are categorized as middle-income countries where private hospitals
can capture local healthcare needs.
The Romanian financial system is benefiting from a growing economy and the
privatization of the banking system as part of the European Union accession process. The
increase in capital and banking sophistication resulting from increased foreign ownership in the
banking sector has led to major branch expansion programs for many of the larger banks to target
retail customers in previously underserved areas.
Given the growth strategy of the larger banks, the private sector's access to credit is
increasing rapidly, particularly in the consumer sector. The smaller banks, which remain locally
owned with underdeveloped franchises, may be compelled by their decreasing market share in
the traditional sectors to pursue growth opportunities in other segments, such as micro, small,
and medium enterprises and the health sector. Larger banks have been keen to lend to new
markets, such as family doctors, and to expand lending activities in markets already served, such
as distributors and pharmacies. However, several factors have inhibited them, including the
nature of the businesses, which have low levels of fixed assets to offer as collateral, and the lack
of reliable market information for loan product development.
Developments in inflation and interest rates reinforce the push for new lending sectors.
Following years of hyperinflation, the authorities are finally succeeding in subduing inflationary
pressures. With narrowing interest margins between loans and deposits, banks are seeking new
sectors for lending where interest margins may be more rewarding.
In Romania, loans for micro, small, and medium enterprises are accessed mainly from
commercial banks and donor-funded multi-financial institutions (MFIs). The Romanian banking
system is highly concentrated, with the five largest banks controlling 60% of the market. Interest
rates continue to be high for micro, small, and medium enterprises, and collateral is generally
required for loans longer than six months and greater than $7,000.
From USAID (2007), there are 14 MFIs in Romania. Many of them are clustered in the
Transylvania region and Bucharest. Their types and sizes vary, with the five largest ones having
a combined market share of less than 25% of the aggregate MFI loan portfolio. 14 Although
some MFIs have collateral requirements, most are open to cash-flow-based lending for short-
term loans. The largest MFIs in Romania include the Center for Economic Development;
Cooperative Housing Foundation -Express Finance; Creditar, Asisenta, si Pregatire pentru
Afaceri Foundation/World Vision; and Opportunity Microcredit Romania.
The leasing market in Romania is in a rapid stage of development, primarily for large
industrial equipment and cars. Some medical equipment-leasing firms exist, and some medical
equipment suppliers will sell on credit. Pharmaceutical distributors also offer credit to their
customers.
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In the research survey done by USAID (2007), among the 94 family doctors who tried to
borrow but were not successful in doing so, the primary reason is that the loan application was
rejected-this was the reason given by almost two-thirds of the respondents (61.7%). It is
possible that the respondents who claim they attempted to borrow but do not cite their
application as being rejected, consider "attempted to borrow" to mean "researched the possibility
of borrowing" or "began but didn't finish the loan application." These interpretations would
explain the following answers. A quarter (24.5%) of respondents mention the fear of being
unable to repay the loan, and almost two-fifths (19.1 %) feel that the process of obtaining a loan
involves too much red tape. As in other emerging countries, limited capabilities prevent potential
organizations from financing for future growth.
Exhibit 4
Reasons for not borrowing
(Romania in 2006)
Application was rejected W
Afraid of being unable to pay it back
Process involves too much red tape
Do not like to borrow money 9%
Bad experience with borrowing in the past 9%:
The USAID (2007) survey also identified hospital needs for growth. As shown in Exhibit
5, 70% of those who would like to borrow in the future would use the loan to purchase medical
equipment, and 68% said that they would like to buy their current office. Over half (53.9%)
would use the loan to refurbish or expand their private practice. More than a quarter of the
respondents (26.3%) would buy computers with the loan. A smaller percentage would provide
other services (13.8%) or hire staff (1 1.5%). Multiple answers were allowed. Since the surveyed
hospitals are small, their financial needs relate to expenditure within the existing hospitals, rather
than the addition of new hospitals.
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Exhibit 5
Financial needs in Romania
Loan needs in Romania (2006)
Buy equipment
Buy current office
Expand/refurbishi current office
68%
54%
Breakdown
(equipment)
Electrocardiograph 63'
Micro-kab equipment
Buy computers 26%
Olter new services 14%
Hire staff 12%
Buy car 5
Purchase land 4%
0% 10% 20% 30%
Sonograph 44%
iurgical instruments
40% 50% 60% 70% 80% 0% 20% 40% 60% 0%
Source: USAID Research Report
USAID (2007) and Smith (2003) indicate the underlying reasons that investors cannot
evaluate the fundamental value of hospital business. Therefore, they offer limited amount of
finance based on a collateral value especially the land and the large equipment. As a result, many
hospitals in emerging countries have suffered from financing from banks.
3. Case: Life Healthcare in South Africa
The chapter plays a transition role toward the case valuation of Life Healthcare. It covers
fundamental healthcare landscape that significantly affects modeling assumptions and historical
business performance of Life Healthcare that is a basis of forecasting. Then, the thesis discusses
the key business issues and risks to set up appropriate assumptions of valuation.
3-1. Healthcare environment in South Africa
In South Africa's hospital industry, we can observe a significant shift from the public
sector to the private sector. Historically, the most basic primary healthcare was offered free by
12
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the state. As the economy has grown, healthcare services became specialized. However, Brand
South Africa (2013) reports that the public sector is stretched and under-resourced in places even
though the public sector contributes approximately 40% of all expenditures on health. The public
health sector is under pressure to deliver health services to approximately 80% of the population
in South Africa. While access to health has improved, the quality has fallen. This is partly due to
poor management and underfunding. On the other hand, the private sector is run largely on
commercial lines and caters to middle- and high-income customers who tend to be members of
private medical schemes plans. Also, the better labor environment attracted healthcare
professionals, especially doctors. In 2011, the total spent on health was R 248.6 billion, 8.5% of
the GDP, significantly above the 5% recommended by the World Health Organization. Of the
total spending on health, 49.2% was for the public sector, covering 84% of the population, or 42
million people. In the private sector, total spending was 48.5%, covering only 16.2% of the
population.
In addition to poor public health services, the issue of doctor shortages should be
mentioned in Brand South Africa (2013). As of March 2012, 38,236 doctors were registered. The
doctor-to-population ratio is estimated to be 0.77 per 1,000, which (even globally) is very low.
Looking at the supply side, approximately 1,200 medical students graduate annually. To deal
with this issue, the government signed a co-operation agreement with Cuba, Tunisia, and Iran.
The government also made it easier for other international doctors to register in South Africa.
This issue may affect the growth of private hospitals as it may hinder them from recruiting a
sufficient number of good doctors.
As shown below, the number of people demanding private healthcare continues to rise as
more South Africans joined the middle-class in terms of financial assets. As a result, medical
plan membership grew 2.5% during 2011 to 8.5 million members, with a 22% increase since
2004. Historically, hospital utilization was mainly driven by the high burden of disease. As more
and more people in South Africa change their lifestyle to a Western one, non-communicable
diseases such as heart disease, cancer, and diabetes have become more common. A high
incidence of communicable diseases such as tuberculosis and pneumonia has also increased
hospital utilization, along with an aging population and fast-changing medical technology.
Recent economic development has allowed an increasing number of people to pay for private
insurance as a result of the significant job creation.
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Exhibit 6
Beneficiaries of private
healthcare schemes (K ppl)
2 6,836 7, 127 7,478 7,874 8,001>-
8,316L- 8,526-
2004 2005 2006 2007 2008 2009 2010 2011
3-2. Business model of Life lealtheare
Life Healthcare's core business is acute private hospital care. The group's head office is
situated in Johannesburg. Its acute care hospitals are complemented by mental health, acute
rehabilitation, renal dialysis, and occupational health business. Life's diversified healthcare
business is organized into three divisions.
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Exhibit 7
Business breakdown (2012)
Services
7%
The annual report in 2012 says that the hospital division represents 93% of the Group's
revenue for the year, comprising the core acute care hospital business and services for acute
physical rehabilitation, acute mental healthcare, and renal dialysis in South Africa and Botswana.
The healthcare services division represents 7% of the Group's revenue for the year, comprising
acute and long-term hospitalization services to public sector patients provided by Life Esidimeni
(meaning "place of dignity"), as well as contracted occupational healthcare provided by Life
Occupational Health to private and public employers. The international division comprises the
Group's 26% interest in Max Healthcare, an acute care hospital business in India.
In operation, it has 50 acute care hospitals with 7,608 registered beds and approximately
2,700 healthcare specialists in urban parts of South Africa from the government website. It also
has seven rehabilitation facilities, six mental health centers, and seven renal dialysis facilities.
They have admitted over 600,000 patients, mainly from the private medically insured market. In
addition to facilities, its group acquired a 26% shareholding in Max Healthcare Institute (MHC),
an Indian hospital group. MHC has nine hospitals with 1,943 beds in Delhi and the surrounding
regions. The Group's strategy is to become a pre-eminent hospital operator in selected offshore
emerging markets with a particular focus on India and specific countries on the African continent.
Looking at its operational performance, Life Healthcare has been on a good track. The
company has achieved a 70%-plus occupancy rate in past years while the industry average is
typically between 65 and 70%. Also, the quality metrics score has been very high. Patient survey
revealed a 98.3% (the average score between 2011 and 2012) satisfaction rate. The net promoter
score (based on the fundamental perspective that every company's customers can be divided into
three categories: Promoters, Passives, and Detractors) is around 95.0%.
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Exhibit 8
Life Healthcare Financial
(R million) %
Income statement 208 2009 2010 2011 2012 CAGR (06-12)
Revenue 5,452 6,146 6,943 7,930 8,786 9,812 10,937 12%
Operating profit 788 1,008 1,546 1,555 1,867 2,173 2,542 22%
% of rev 14% 16% 22% 20% 21% 22% 23%
Profit after tax 334 505 964 937 835 1,492 1,743 32%
% of rev 6% 8%1 14% 12% 10% 15% 16%
Balance sheet
Total assets 6,561 7,032 6,939 6,887 7,872 8,468 9,256 6%
Total Liabilities 5,637 5,573 4,589 3,957 4,357 4,084 4,378 -4%
Total equity 924 1,459 2,350 2,930 3,515 4,384 4,878 32%
DuPont analysis
ROA 12% 14% 22% 23% 24% 26% 27%
OP margin 14% 16% 22% 20% 21% 22% 23%
D/D+E ratio 86% 79% 66% 57% 55% 48% 47%
Operation
Number of beds 6543 6705 7021 7190 7669 7916 8227 4%
Rev per beds (R mil) 0.83 0.92 0.99 1.10 1.15 1.24 1.33
Paid patient days (K) 1502 1614 1694 1762 1807 1904 2021 5%
Source: Annual report
Its overall performance has been great in the last seven years.
compounded annual growth rate (CAGR) of 12% and profit after tax
This significant growth came from both an increase in the number of
Revenue grew with a
increased by 32% CAGR.
beds and revenue per beds.
In particular, the revenue per bed went up as paid patient days increased. This implies that the
hospital was able to deal with challenging operations and sickness and that more and more
patients could afford good medical insurance. Therefore, its asset turnover, such as ROA and
operational profitability, has improved in past years. Looking at the wealth distribution analysis
below, apart from employee salary, the company did not allocate a lot into capital investment,
such as the addition of new hospital facilities and mergers and acquisitions. As a result, the debt
ratio has decreased since the organization has reserved cash as equity.
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Exhibit 9
Wealth distribution analysis (2012)
Employees 53%
Provides of equity 15%
Reinvestment 11%
Government 11%
Capital maintenance 7%
Provides of funding 3%
Source: Annual Report
The future strategy at Life Healthcare is to focus on growth by developing the breadth
and depth of their existing southern African hospital network and expanding the coverage and
penetration of the southern African market. It plans to expand facilities within existing hospitals
by adding additional beds, wards, and operating theatres. Also, Life Healthcare intends to
introduce new services and disciplines at selected hospitals where there is an opportunity to
create niches. In particular, the new lines of business will focus on mental healthcare acute
rehabilitation and renal dialysis. Furthermore, it plans to increase the geographical coverage
within southern Africa to meet the increasing demand for private healthcare. The approach will
involve the acquisition of select facilities that complement its existing geographic spread of
hospitals and to build new facilities where there is no existing coverage. Accordingly, the future
capital expenditure plan is to set up additional beds and potential mergers and acquisitions. In the
annual report, Life Healthcare puts forth that the demand for hospital services will increase
continuously due to the high incidence of disease together with a growing medical aid population,
the impact of aging, and preferred network arrangements.
3-3. Key business drivers
The greatest upside potential for private hospitals in South Africa lies in the ability of the
South African economy to create a meaningful number of new jobs. Job creation in the formal
sector results in more people with access to private medical insurance and therefore a greater
amount of private healthcare spending. However, some equity research teams have expressed
concerns that job creation in South Africa will continue to be hindered by dogmatic unions,
globally uncompetitive wages, poor productivity, and an inflexible employment equity charter.
Nevertheless, job growth should see some cyclical pickup as the global economy heals itself.
Moreover, the African National Congress (ANC) remains under pressure to generate jobs.
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Whilst JP Morgan (2011) expects subdued job growth into 2012, it should nevertheless
pick up and job growth is forecast to recovering to -300,000 annually by 2015. This should help
drive the increased medical plan membership, as outlined below.
Life's growth should continue to outstrip its rivals domestically, given its focus on the
lower end and Government Employee Medical Scheme (GEMS). It is now mandatory for all new
government employees to be placed on the GEMS scheme. This has resulted in the number of
GEMS beneficiaries growing by 36% in 2010 to 1.6 million. In addition, the preferred supplier
agreement has with Discovery's healthcare medical scheme, where it has a 45% share (313,112
total beneficiaries), continues to provide Life with strong volume growth. Approximately 41% of
Life's turnover is now generated from GEMS (-15%) and Discovery (26%). Life's Alternative
Reimbursement Models (ARMs), which cover -65% of revenue, offer greater proportions of
fixed-fee work, which encourages efficiency on the hospital side and has won significant favor
with funders.
Greater job growth or reform of the prescribed minimum benefits could accelerate
medical scheme membership. Moreover, any great leaps forward in demand would come up
against the shortage of doctors and nurses relatively quickly-any government reforms will have
to carefully factor in potential skill shortages.
Exhibit 10
South African Job Growth (K ppl)
Jobs creation 175 200 226 250 300 14%
Public sector jobs (GEMS*) 100 90 90 80 80 -5%
Private Sector Jobs 75 110 136 170 220 31%
Private Sector Conversion 40% 40% 40% 40% 40% 0%
Private Sector Health Insurance Take-Up 30 44 54 68 88 31%
Total New Medical Scheme Members 130 134 144 148 168 7%
* GEMS (Government Employee Medical Scheme)
Source: J.P. Morgan estimates
The second key driver is the aging trend in South Africa. The African Development Bank
(2011) reported aging in South Africa due to the decreased fertility rate and improved life
expectancy at birth. The U.S. Bureau (1997) also shared their estimated ratio of the 60+
population in South Africa: 6.8% in 1997, 8.6% in 2010, and 10.8% in 2015. The core insured
South African population continues to age and healthcare spending increases dramatically as an
individual ages. As individuals age, the number of hospital visits rises and the procedures
performed become more specialized, resulting in higher income per bed day. Netcare, a large
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hospital chain in South Africa, reported in the annual report that average hospital costs are 67%
higher for those aged over 50 than those below 50. Couple the impact of aging on the core
insured market to the higher burden of disease typically present in the lower income scheme
membership and it is easy to see why Life's utilization rates are rising.
3-4. Risks and considerations
The biggest risk is the regulatory environment. The healthcare industry in South Africa is
subject to government regulations relating to licenses, conduct of operations, and security of
medical records, quality standards, and certain categories of pricing. Furthermore, the labor
Relations Act and the Employment Services Bill may affect employment cost in life healthcare.
Second, the national health insurance trend is a key consideration. The government
released a green paper on national health insurance in August 2011. The green paper provided a
high-level strategic direction for national health insurance but did not provide sufficient detail
regarding how it would be implemented. The funding proposal is expected to be made known
later in 2013. Life Healthcare can be expected to face pricing issues. The competition
commission is considering an inquiry into private healthcare industry prices. The terms of the
inquiry have not yet been released, but it is expected to last at least two years and cover the
major cost drivers in the industry and benchmark its costs internationally.
Third, Life Healthcare may suffer from a shortage of recruits, namely, doctors and skilled
people in hospitals in emerging countries. In general, not enough doctors are being trained to
address the health needs of, and general shortage in, the country. Since several major hospital
chains are expanding their operations and are competing to hire great doctors, Life Healthcare
may not be able to hire enough. South Africa also has an increasing shortage of nurses,
pharmacists, and other healthcare professionals. It was recently reported that the effects of
HIV/Aids on staff are becoming significant by Brand South Africa (2013)
4. Valuation
In valuation analysis, there are two common approaches to evaluate business. The first is
multiple analysis and the second is discounted cash flow analysis. In the chapter, the thesis
touches upon two valuation methodologies including concepts, calculation steps, and
implications by reviewing the financial literature. Then, the paper reaches out the conclusion that
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discount cash flow model is more appropriate to understand the key drivers and conduct
sensitivity analysis rather than multiples.
4-1. Multiples
Multiple analysis is a common methodology that is used for valuing a target company
since it gives a market benchmark that is comparable with competitors. Typically, comparable
company analysis has a broad range of applications, most notably for mergers and acquisitions,
initial public offerings, restructurings, and investment decisions. The biggest assumption in
multiple analysis is that similar companies can provide a highly relevant reference value point
for valuing a given target due to the fact that they share key business and financial characteristics,
key business drivers, and downside considerations. As a result, practitioners can establish
valuation parameters for the target by deciding its relative positioning among benchmarks. The
key of the analysis includes selecting a universe of comparable organizations for the valuation
target. These peers are benchmarked against one another and the target based on various
financial statistics and ratios. Typically, the valuation range is estimated by using several
multiples with market price and some revenue or profit figures. The selection of valuation
metrics can vary by sector, based on type of asset composition, profitability, and cash flow
turnover. Example multiples are enterprise value to earnings before interest, taxes, depreciation,
and amortization (EV/EBITDA) and price to earnings (P/E). While P/E is the most broadly
recognized in the investment banking industry, bankers also use multiples based on enterprise
value because they are independent of capital structure and other factors unrelated to business
operations, such as differences in tax regimes. One important problem is that multiple analysis
with peers is designed to reflect current (not fundamental) valuation based on prevailing stock
market conditions and sentiment. For example, market conditions are subject to irrational
investor sentiments that skew valuation either too high or too low.
From Rosenbaum, Pearl, and Perella (2009), a famous practice guidebook for investment
banking, a multiple analysis has four steps. The first is to define the universal scope of
comparable companies. Preferably, comparable companies conduct similar operations in the
same location. Even competitors focus on different customer segments. If the target is pure-play,
then comparable should be a pure-play company. If the target is a large portfolio company such
as General Electronics, then we should give a detailed comparison. In that case, we need to select
the most similar companies. The second step is to gather the necessary financial information.
Once the initial comparable universe is defined, we need to analyze all figures to identify their
performance. The sources of this information are company's SEC filings, consensus research
estimates, equity research reports, press releases, and financial information services.
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The third step is to spread key statistics, ratios, and trading multiples for the comparable.
This step involves calculating market valuation, such as enterprise value and equity value. A
variety of ratios and other metrics measuring profitability, sales growth, and credit strength are
also calculated at this stage. This analysis provides the basis for establishing relative ranking as
well as determining which companies are most appropriate for framing its valuation. Finally, we
need to benchmark comparable companies and determine valuation as a relative value.
Benchmarking plays an important role in determining the relative strength of comparable
companies versus one another and the target. After calculating multiples, we can get the
appropriate valuation range. The selected range is then applied to the target's relevant financial
figures to produce an implied valuation range. As this process involves as much art as science,
senior investment bankers are usually consulted for guidance on the final investment decision.
4-2. Discounted cash flowN
Rosenbaum, Pearl, and Perella (2009) states that a discounted cash flow analysis is a
fundamental valuation methodology that is broadly used by investment bankers, corporate
officers, university professors, investors, and other finance professionals. It is premised on the
principle that the value of a company, division, business, or collection of assets can be
determined from the present value of its projected free cash flow. A company's projected free
cash flow comes from a variety of assumptions and judgments about its forecasted financial
performance, including sales growth rates, profit margins, capital expenditures, and net working
capital requirements. Discounted cash flow analysis has a wide range of applications for
valuations for M&A, IPOs, corporate restructurings, and decision making of investments.
Financial professionals call this value the "intrinsic value." This is the opposite of the market
value obtained by comparing benchmarked businesses or organizations. As a result, discounted
cash flow analysis serves as a meaningful alternative approach to market-based valuation like
multiples. This analysis is especially effective when evaluators can find limited pure-play, peer,
or comparable businesses.
Practically, discounted cash flow is projected for the next five years based on information
availability and estimation accuracy. Provided that the inherent difficulties in accurately
estimating financial performance over an extended period of time are considered, a terminal
value is used to capture the remaining value of the target beyond the projection period, which is
equivalent to the "going concern" value.
The projected free cash flow and terminal value are discounted at the target's weighted
average cost of capital (WACC). This cost is a discount rate that is commensurate with its
business and financial risks. The present value of the free cash flow and terminal value are
summed to define a corporate value. The assumptions of WACC and terminal value assumptions
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typically affect the output. Therefore, a discounted cash flow output is viewed in terms of a
valuation range based on a set of assumptions, rather than a single value. Then, we use
sensitivity analysis to test the impact of these assumptions.
Typically, the discounted cash flow approach is composed of five steps to calculate the
enterprise value. The first step is to examine the target and identify key drivers of performance. It
is critical to have a holistic view of the target from the macro environment to micro operational
issues. This involves finding key factors of sales growth, profitability, and free cash flow
generation. The second step is to project free cash flow. This exercise helps us to estimate the
cash generated by a company after paying all cash operating expenses and taxes, as well as the
funding of capital expenditure and working capital, but prior to the payment of any interest
expense. In most cases, practitioners conduct projections for a period of five years. However, this
term may change depending on the sector, business model, stage of development, and
predictability. The objective of predicting a free cash flow is to identify a point in the future
when the target's financial performance is deemed to have reached a "steady state. The third step
is to calculate the WACC. WACC is used to discount the target's projected free cash flow and
terminal value to the present. This exercise requires calculating both the equity cost of capital
and the debt cost of capital. In evaluating public companies, it is relatively easy to calculate the
equity cost of capital from beta with benchmark organizations. In this case, the challenging part
may be the cost of debt since it is not risk-free in emerging countries. Then, rating agencies such
as Standard & Poor's provide a B-class rating to governmental bonds. Also, WACC is dependent
on capital structure. The fourth step is to define the terminal value. The terminal value is based
on the remaining value of the target after the projection period. We need to assume fundamental
growth rates. The final step is to calculate the present value and to finalize valuation. This is not
only to sum up the free cash flow and the terminal value-if some key drivers are influential and
have high volatility. It is worth conducting a sensitivity analysis to see the different sets of value
in different stories.
From Ross, Westerfield, and Jordan (2012) and Rosenbaum, Pearl, and Perella (2009),
discounted cash flow assumptions have both strengths and weaknesses. On the positive side, the
use of defensible assumptions helps shield the target valuation from market distortions that
happen based on investor perspectives. Additionally, the discounted cash flow approach provides
flexibility in analyzing the target's valuation under different scenarios by adjusting the
underlying inputs and checking the resulting impacts. However, on the negative side, when we
want to see market values in order to capture investment opportunities, especially in a short time
frame, it may fail to adequately capture the realistic set of values.
In this thesis, the objective is to identify fair value based on business potential and also to
understand what the key drivers are to increase enterprise value in emerging countries.
Forecasting the market price is not a primary objective. Rosenbaum, Pearl, and Perella (2009)
suggests that a discount cash flow model is usually an effective approach to reflect business
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potential due to flexible assumptions. Accordingly, we adopt a discounted cash flow model to
evaluate Life Healthcare Group.
4-3. Valuation of Life Healthcare
In this thesis, the major objective is to gain perspective in valuation, rather than to
identify the fundamental market value. To compare the valuation result with other valuations
conducted by equity research analysts, this thesis considers the FY201 I dataset as the baseline
and forecast figures from 2012. The big picture of the discounted cash flow valuation approach
for Life Healthcare Group will be shown. Key assumptions to predict future cash flow and
terminal value will be defined. Enterprise value will be calculated as the sum of the present value
of future cash flow and terminal value.
In this case, we forecasted figures in the nearest five years as free cash flow and then
calculated the terminal value by assuming a long-term growth ratio.
4-4. Key assumption
The table below shows the major assumptions in each financial statement. First, Life
Healthcare Group has achieved 12% sales growth over the past five years. On the other hand, it
is reasonable to consider that the growth rate will converge with the long-term economic growth
rate since healthcare is a domestic and stable industry. In advanced economies, growth of the
healthcare industry is close to the overall economic growth rate. Therefore, this thesis assumes
that the current strong growth will not last long, even with the aging society and the increase in
private insurance members. For profitability, a forecasted margin was created on the basis of the
historical average because the EBIT margin has been stable in the past. Additionally, due to the
shortage of doctors, personnel costs will soar. The profitability has therefore been adjusted to
20%.
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Exhibit 11
Major items Assumption
Income Statement
Sales growth Starting from historical average and go down to long-term growth rate
EBIT Margin 20% (Historical average was 20+%)
Balance Sheet
Accounts Receivable Historical average of ratio (AR/Sales)
D/E ratio Maintain 2011 figure
Net Debt Calculation
Net Working Capital Calculation
Cash flow
Tax rate Historical average (28%)
D&A Historical average (D&A/PPE)
Dividends Historical average (Payout ratio)
Others
WACC Government bond rate (6.5%) + risk premium (1.5%)
In the balance sheet, inventory figures, such as accounts receivable, are assumed to be a
ratio of sales. The debt to equity (D/E) ratio is important. As we learned in the previous chapter,
because of its high profitability and abundant cash, Life Healthcare is holding a decreased D/E
ratio with an increased number of hospital beds at a moderate pace. Assuming that the future D/E
ratio is strong, then Life Healthcare will coordinate the debt to invest in additional facilities as
capital expenditure, which will allow it to balance the D/E ratio.
Finally, WACC was set at 8%. The rational for this is that the corporate rate can include an
additional country rate and industry risk premium. In South Africa, the government can arrange
its finances, paying interest of 6.5%. In developed countries, the healthcare industry premium is
I to 2% on average.
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4-5. Valuation results
This subchapter reviews the valuation result and discusses the difference from valuation
from other financial players, such as Deutsche Bank (2011), Morgan Stanley (2012), and J.P.
Morgan (2011). The table below shows a summary of the valuation. Based on the assumptions,
the five-year cash flow from 2012 to 2016 is calculated to be 7,069 in R million. The net present
value of the terminal value with an 8% growth rate is estimated to be 38,432 in R million. After
adjusting the net debt value, the equity value is 43,301. At the end of FY 2011, the number of
shares was 1,042 million. Thus, the estimated valuation per stock is 41.6.
Exhibit 12
Life Healthcare DCF Valuation
(R million)
- Summary
2011 2012(E) 2013(E) 2014(E) 2015(E) 2016(E)
2,173
474
(5)
2,198
432
(29)
2,429
465
(19)
2,647
507
(23)
2,846
521
(27)
3,017
532
(32)
2,642 2,601 2,875 3,131 3,340 3,517
(608) (615) (680) (741) (797) (845)
(630) (713) (819) (923) (1,032) (1,155)
1,404 1,272 1,376 1,467 1,511 1,517
Terminal Value
NPV(TV)
NPV(2011-16)
Net dept
Equity
Number of shares
Value per share
WACC
ST growth
LT growth
56,470
38,432
7,069
(2,200)
43,301
1,042
41.6 (ZAR)
8%
12% 11% 9% 8% 6%
4%
However, 41.6 is just the base price. We need to look at valuation ranges with changes in
key influential factors such as the weighted average cost of the capital and the long-term growth
rate in sales. The following table shows sensitivity analysis results. When we change WACC
from 7 to 9% and the long-term growth rate from 3 to 5%, then the analysis identified the
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EBIT
D&A
Wcap
Ops CF
Tax
Capex
FCF
valuation range as between 27.8 and 82.8 in ZAR. The second table, "Difference from Base,"
shows how much the value will change in each case. It was found that the weighted average cost
of capital is more influential for the valuation price than the long-term growth rate.
Exhibit 13
Sensitivity analysis Base
Valuation (ZAR)
LT Growth
WACC 3.0% 3.5% 4.0% 4i5% 5.0%
43.1 48.8 56.3 66.9 82.8
38.0 42.3 47.9 55.3 65.7
33.9 37.3 41.6 47.0 54.3
30.6 33.3 36.6 40.8 46.2
27.8 30.0 32.7 36.0 40.1
Difference from Base
LT Growth
WACC 3.0% 3.5% 4.0% 4.5% 5.0%
1.5 7.2 14.7 25.3 41.2
-3.6 0.7 6.3 13.7 24.1
-7.7 -4.3 0.0 5.4 12.7
-11.0 -8.3 -5.0 -0.8 4.6
-13.8 -11.6 -8.9 -5.6 -1.5
Finally, when we look at comparisons with other valuations, our valuation has the highest
value. Deutsche Bank (2011) and J.P. Morgan (2011) made a very conservative assumption on
profitability and sales growth. Their judgments of valuation were neutral and their valuation
prices were very close to the price at the timing of valuation. Morgan Stanley (2012) assumed a
very positive perspective of the private healthcare market in South Africa. After the valuation
timing at the end of 201 1, the stock price increased by 50%, reaching 32.2. The source of the
difference may be optimistic profitability and future sales growth. Other investors may see the
20% EBIT margin as too high, even in the regulated hospital industry. It is challenging to find
the right number for long-term growth. Typically, forecasters put the fundamental GDP growth
rate as the long-term growth rate. Based on the valuation comparison below, investors would be
a bit conservative by setting the long-term growth rate low.
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7.0%
7.5%
8.0%
8.5%
9.0%
7.0%
7.5%
8.0%
8.5%
9.0%
Exhibit 14
Valuation (ZAR, End of FY11)
Valuation
Morgan Stanley
Deutsche Bank
J.P.Morgan
Stock price (2011 Dec)
Stock price (2012 Dec)
41.6
34.0
22.0
21.5
21.0
32.2
5. Lessons and next steps
Based on valuation results and considerations, this chapter reviews key lessons of
valuation in emerging countries and leaves several ideas to improve quality of valuation work for
financial practitioners.
5-1. Lessons
Through the valuation exercise, numerous lessons and challenges were identified. First,
the perspective of growth is critical. When calculating business value in emerging countries,
setting the right growth rate is always debatable, partly because the figures look much higher
than those in advanced economies. Sometimes people cannot believe that a 10+% growth rate
would be sustainable. This thesis followed a common assumption that the long-term market
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growth rate will finally converge to the country's economic growth rate. We need to assess the
market carefully to make more reasonable assumptions. In the hospital industry of South Africa,
some industry experts predict a high growth rate of at least 10 to 12% for the next ten years
because of the high demand for private healthcare services and the increasing number of affluent
people who can afford to join private insurance schemes. To figure out how the growth rate
should be set in the future, additional microanalysis on a detailed level is needed. That level of
detailed analysis allows investors to capture the value of the long-term growth.
Understanding the business model is always important. In emerging countries, business
models are not the same as those of developed countries because labor and transaction costs are
totally different and sales sometimes depend on governmental actions and regulations. In the
healthcare domain in particular, the service delivery model evolved differently. We can observe
an integrated value-chain in specific areas such as eye care. This perspective is critical when
investors conduct comparable analysis with multiples and try to set up profitability assumptions
based on competitors across countries. Profitability varies based on specific business domains,
from general hospitals, specialized hospitals, clinics, and diagnosis facilities.
The impact of changes in regulation is large. The private health market is affected by
improvements in public healthcare services, which many affluent domestic customers
complained about. If the South African government changes the scope and quality of health
services in a positive way, then potential customers in the middle class may stay at public
facilities and not shift to private schemes. Additionally, it is said that the low quality of doctors is
a big issue. If the government creates additional educational requirements for medical students
by extending their study time period, private hospitals including Life Healthcare will be affected.
Sustainable service delivery is key. Resources are not always ready. Especially in terms
of talent, unlike advanced economies, the number of doctors and nurses is not sufficient. Even in
the future, the supply of healthcare workers will be limited. As such, it is expected that it will
cost more to hire and retain good doctors. This will affect the growth strategy of private hospitals.
They may need to decrease the speed of facility expansion by adding new beds in existing
hospitals or by adding new hospitals in South Africa. Equipment and medicine are also not
available all the time. In terms of investment evaluation, financial practitioners can establish two
different scenarios.
Estimating the capital cost for both the short and long term is very challenging. First,
capital cost in emerging countries is not stable over time. As the economy develops, the risk of
governmental bonds decreases. It may then be required to set a different level of interest rates
every ten years. Second, even though the risk-free interest rate in emerging countries is high,
currency volatility is a key consideration for international financial investors.
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5-2. Next steps
This thesis examined private healthcare business development, financial needs, valuation,
looking at Romania issues and case example of Life Healthcare in South Africa. The need for
good-quality healthcare is substantial, but the supply side, especially in emerging countries, is
not yet able to satisfy all of the needs. Private organizations try to expand their operations by
adding new facilities and equipment. Accordingly, they have significant financial needs from
financial institutions. However, many loan applications are declined in developing countries,
partly due to a lack of capability in evaluating the private hospital business. This thesis assessed
the business potential by examining the market growth, risk profile, and weighted average cost of
capital with discounted cash flow valuation model to examine fair value of Life Healthcare in
South Africa. The valuation in this thesis had a similar enterprise value as the current stock price.
It also shows that evaluating the market potential in a detailed way can identify the
underestimated long-term growth. It may give investors the incentive to assess the market
potential carefully and policy makers the motivation to fill the information gap.
It is of note that some assumptions are critically examined. Specifically, the market
growth and cost of capital needs to be examined on a more detailed level. Governmental actions
and regulations can be considered with scenario analysis. In terms of the discount factor, it
should be set on the basis of investor positioning. International investors may want to establish a
higher risk premium based on currency volatility and political risks. Country risk changes as
countries develop.
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